Cargando…

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study

SIMPLE SUMMARY: Pancreatic cancer is a significant problem worldwide. Most cancers are diagnosed at an advanced stage. Limited knowledge of the pathogenesis of pancreatic tumors results in limited diagnostic and therapeutic possibilities. Using metabolome analysis, we identified unique metabolite pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skubisz, Karolina, Dąbkowski, Krzysztof, Samborowska, Emilia, Starzyńska, Teresa, Deskur, Anna, Ambrozkiewicz, Filip, Karczmarski, Jakub, Radkiewicz, Mariusz, Kusnierz, Katarzyna, Kos-Kudła, Beata, Sulikowski, Tadeusz, Cybula, Patrycja, Paziewska, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296343/ https://www.ncbi.nlm.nih.gov/pubmed/37370852 http://dx.doi.org/10.3390/cancers15123242

Ejemplares similares

Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
por: Starzyńska, Teresa, et al.
Publicado: (2020)

The gastric microbiota in patients with Crohn’s disease; a preliminary study
por: Ostrowski, Jerzy, et al.
Publicado: (2021)

High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years
por: Waker, Edyta, et al.
Publicado: (2020)

Higher genome variability within metabolism genes associates with recurrent Clostridium difficile infection
por: Kulecka, Maria, et al.
Publicado: (2021)

Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report
por: Błogowski, Wojciech, et al.
Publicado: (2014)

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
por: Rosiek, Violetta, et al.
Publicado: (2023)

Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma
por: Skubisz, Karolina, et al.
Publicado: (2021)

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
por: Rosiek, Violetta, et al.
Publicado: (2023)

Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report
por: Blogowski, Wojciech, et al.
Publicado: (2022)

Treatment of neuroendocrine tumors: new recommendations based on the CLARINET study
por: Kos-Kudła, Beata
Publicado: (2015)

Mediastinal Pancreatic Pseudocysts
por: Dąbkowski, Krzysztof, et al.
Publicado: (2017)

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
por: Malczewska, Anna, et al.
Publicado: (2019)

Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Gola, Michał, et al.
Publicado: (2022)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

An Attempt to Evaluate Selected Aspects of “Bone–Fat Axis” Function in Healthy Individuals and Patients With Pancreatic Cancer
por: Blogowski, Wojciech, et al.
Publicado: (2015)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

Endoscopic findings in the upper gastrointestinal tract in patients with Crohn’s disease are common, highly specific, and associated with chronic gastritis
por: Graca-Pakulska, Katarzyna, et al.
Publicado: (2023)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
por: Malczewska, Anna, et al.
Publicado: (2020)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer
por: Starzyńska, Teresa, et al.
Publicado: (2013)

Mass Spectrometry-Based Comprehensive Analysis of Pancreatic Cyst Fluids
por: Paziewska, Agnieszka, et al.
Publicado: (2018)

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
por: Malczewska, A., et al.
Publicado: (2020)

MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
por: Farrell, Amy S., et al.
Publicado: (2017)

Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors
por: Molasy, Bartosz, et al.
Publicado: (2022)

Evidence of Stem Cells Mobilization in the Blood of Patients with Pancreatitis: A Potential Link with Disease Severity
por: Dąbkowski, Krzysztof, et al.
Publicado: (2022)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
por: Guo, Chuangen, et al.
Publicado: (2018)

Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
por: Ren, Shuai, et al.
Publicado: (2019)

Mixed ductal-neuroendocrine carcinoma with unique intraductal growth in the main pancreatic duct
por: Hirata, Koji, et al.
Publicado: (2019)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
por: Zhong, Yanqi, et al.
Publicado: (2023)

Utility of fistula risk score in assessing the risk of postoperative pancreatic fistula occurrence and other significant complications after different types of pancreatic neuroendocrine tumor resections
por: Molasy, Bartosz, et al.
Publicado: (2022)

MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas
por: Xu, Jiake, et al.
Publicado: (2022)

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
por: Rosiek, Violetta, et al.
Publicado: (2023)

Rare Non-Neuroendocrine Pancreatic Tumours
por: Mormul, Agata, et al.
Publicado: (2023)

Expression of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor in Pancreatic Ductal Adenocarcinomas, Neuroendocrine Tumours and Chronic Pancreatitis
por: Angelescu, Radu, et al.
Publicado: (2013)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ihrp4ub096lfk5ljs16sqkvh0c